| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $235K | -33.4% |
| R&D Expense | $54.4M | +28.6% |
| SG&A Expense | $13.8M | +6.1% |
| Operating Income | -$67.9M | -23.7% |
| Pre-tax Income | -$64.0M | -27.0% |
| Income Tax | $0 | — |
| Net Income | -$64.0M | -27.1% |
| EPS (Basic) | -$0.86 | +8.5% |
| EPS (Diluted) | -$0.86 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.1M | -51.0% |
| Current Assets | $82.0M | -20.4% |
| Total Assets | $96.8M | -19.7% |
| Current Liabilities | $15.0M | -8.8% |
| Stockholders' Equity | $70.0M | -22.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.1M | -108.1% |
| Capital Expenditures | $65K | -98.5% |
| Investing Cash Flow | $17.2M | +185.6% |
| Financing Cash Flow | $39.9M | -39.8% |
| Free Cash Flow | -$69.2M | -84.8% |
| +8.5% |